The industrial park covers an area of 11.12 hectares and integrates the R&D of innovative antibody drugs as well as the production and sales of unadulterated liquids and other preparations.
In the future, MLS Health Technology Co Ltd will carry out research and development, packaging, module production, and finished product sales of ecological air purification products.
